Every January, MIT Technology Review's editors lock in on ten breakthroughs they believe will shape the year ahead. It's a rigorous process—dozens of candidates pitched, debated, sometimes agonized over. But the real insight often lives in what gets left out.
The editors recently shared four technologies from this year's "reject pile," and the reasoning reveals something important about how progress actually works: timing matters as much as potential.
Male Contraceptives on the Horizon
New treatments for male contraception are moving through clinical trials right now. Contraline is testing a daily gel that suppresses sperm production and a device that blocks sperm during ejaculation. Another company, YourChoice Therapeutics, has a once-a-day pill in early trials. The progress is real—Contraline's CEO was recently named to MIT Technology Review's Innovators Under 35 list—but here's the catch: these treatments still need years of clinical trials before they reach people. The science works. The timeline doesn't quite fit a "breakthrough" label yet.
We're a new kind of news feed.
Regular news is designed to drain you. We're a non-profit built to restore you. Every story we publish is scored for impact, progress, and hope.
Start Your News DetoxWorld Models: Exciting, but Early
AI researchers have become obsessed with world models—systems trained on videos that can generate 3D virtual worlds from simple prompts. They understand physics. They could transform game design and make robots smarter by helping them grasp their physical environment. Yann LeCun and Fei-Fei Li have both launched companies around the idea. Google released Genie 3 earlier this year. The momentum is undeniable. But the editors decided it felt premature to crown it a breakthrough. Sometimes the most interesting thing is watching a field catch fire before declaring victory.
Proof of Personhood: A Problem Looking for Scale
As deepfakes and AI agents become more convincing, the question "Is this real?" has become urgent. OpenAI, Microsoft, Harvard, and MIT are all developing digital identity tokens—credentials that would verify you're actually human when you log into your bank account or sign important documents. The concept is sound. The problem is fragmentation: multiple competing projects exist in various stages of development, from World ID (using biometric verification) to others still in early phases. Until one approach reaches critical mass or becomes a universal standard, it's a solution waiting for its moment.
The Oldest Baby: Norms Shift Faster Than Technology
In July, an infant born from an embryo frozen for over 30 years set an unusual record. The achievement relied partly on safer IVF thawing methods, but the real enabler was something quieter: the rise of embryo adoption agencies that made people more willing to use decades-old embryos. This could help find homes for millions of frozen embryos sitting in storage banks. But the editors noticed something: the breakthrough here wasn't technological. It was cultural. Norms shifted. Technology followed. That's not quite the same as a technology breakthrough.
What emerges from this list is a pattern: real progress often looks like patience. Male contraceptives, world models, identity verification, and embryo adoption aren't failures. They're technologies and ideas waiting for the moment when timing, technology, and adoption align. Sometimes the most important breakthroughs are the ones that take a little longer to arrive.
